Abdominal surgeries are major surgical procedures that are performed at any teaching hospital. Pain control is major concern in the intra-operative as well as post-operative period in these patients. Optimal pain control in post-operative period is directly related to patient's recovery, shortens the patients' hospital stay and overall burden on health facilities. Inadequate pain control may affect quality of life and increases patient's morbidity and mortality. Different modalities for pain control are used in post-operative period. Opioids are mainstay of treatment in post-operative period but historically are associated with significant side effect profile like dependence, nausea, vomiting, respiratory depression, constipation and many others. Dexmedetomidine is centrally acting α-2 adrenoceptor agonist.
This randomized controlled trial was conducted at Department of Anesthesia, Sahiwal Teaching Hospital, Sahiwal. After institutional review board (IRB) approval, computer-generated random number table was used to randomize the patients to two groups, one group received Bupivacaine plus placebo and the other group received Bupivacaine plus dexmedetomidine. A total of 64 patients met the inclusion criteria and were enrolled in the study in a 1:1. Informed written consent was obtained from all the patients before enrolling them in the study. All patients underwent a pre-operative assessment on the day before surgery. Both groups received wound infiltration with studied drugs at the end of surgery. After surgery patients were shifted to post-surgical ward and assessed for pain using visual analogue scale (VAS) and data was collected and analyzed using Statistical Package for the Social Sciences (SPSS) version 26. Quantitative variables were presented with mean ±SD. Comparison of quantitative variable between groups was done using independent sample t-test. Comparison of qualitative variable like (Opioid sparing effect, Bradycardia, Hypotension, Nausea, Vomiting) was presented with frequency and percentages. Data was stratified on the basis of gender and age. Post-stratification chi-square test was used to compare both groups for opioid sparing effect in each stratum with p-value ≤0.05 as significant.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
64
drug was given at the end of surgery
drug was given at the end of surgery
Sahiwal Medical College
Sahiwal, Punjab Province, Pakistan
Duration of analgesia
Time from procedure to requirement of rescue analgesia
Time frame: Every 30 mints for 4hrs than 2hrly for 24 hrs post procedure
Opioid sparing
Total amount of opioid consumtion in the first 24 post procedure.
Time frame: Total dose of nalbuhine consumption in 1st 24 hrs after procedure
Blood pressure
Mean pressue will be measured
Time frame: Every 15 minutes intra operative and every 15 minutes for 24 hrs postoperatively
Hear rate
Heart rate will be measured
Time frame: Every 15 minutes intraoperative and every 15 minutes postoperatively for 24 hrs
Neausea
Felling of nasueas
Time frame: Every 30 minutes for 4 hrs then 2hrly for 24 hrs
Vomiting
Urge to vomit
Time frame: Every 3 minutes for first 4 hrs then 2hrly for 24 hrs
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.